Journal article
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
Aung Ko Win, Mark A Jenkins, James G Dowty, Antonis C Antoniou, Andrew Lee, Graham G Giles, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Dennis J Ahnen, Stephen N Thibodeau, Graham Casey, Steven Gallinger, Loic Le Marchand, Robert W Haile, John D Potter, Yingye Zheng, Noralane M Lindor, Polly A Newcomb, John L Hopper Show all
Cancer Epidemiology Biomarkers and Prevention | AMER ASSOC CANCER RESEARCH | Published : 2017
Grants
Awarded by National Cancer Institute, NIH
Awarded by Australasian Colorectal Cancer Family Registry
Awarded by Mayo Clinic Cooperative Family Registry for Colon Cancer Studies
Awarded by Ontario Familial Colorectal Cancer Registry
Awarded by Seattle Colorectal Cancer Family Registry
Awarded by USC Consortium Colorectal Cancer Family Registry
Awarded by Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute
Awarded by California Department of Public Health as part of the statewide cancer reporting program
Awarded by National Cancer Institute's Surveillance, Epidemiology and End Results Program
Awarded by NIH
Awarded by Centre for Research Excellence
Awarded by National Health and Medical Research Council (NHMRC), Australia
Awarded by Cancer Research UK
Funding Acknowledgements
This work was supported by grant UM1 CA167551 from the National Cancer Institute, NIH, and through cooperative agreements with the following Colon Cancer Family Registry (CCFR) centers: Australasian Colorectal Cancer Family Registry (U01/U24 CA097735), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01/U24 CA074800), Ontario Familial Colorectal Cancer Registry (U01/U24 CA074783), Seattle Colorectal Cancer Family Registry (U01/U24 CA074794), and USC Consortium Colorectal Cancer Family Registry (U01/U24 CA074799). Seattle CCFR research was also supported by the Cancer Surveillance System of the Fred Hutchinson Cancer Research Center, which was funded by contract numbers N01-CN-67009 (1996-2003) and N01-PC-35142 (2003-2010) and contract no. HHSN2612013000121 (2010-2017) from the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute with additional support from the Fred Hutchinson Cancer Research Center. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. P.A. Newcomb, M.A. Jenkins, J.G. Dowty, J.L. Hopper, N.M. Lindor, R.J. MacInnis, and Y. Zheng received support for this study by grant R01CA170122 from NIH. M.A. Jenkins, J.L. Hopper, and G.G. Giles received further support from Centre for Research Excellence grant APP1042021 and program grant APP1074383 from National Health and Medical Research Council (NHMRC), Australia. A.K. Win is a NHMRC Early Career Fellow. M.A. Jenkins is an NHMRC Senior Research Fellow. J.L. Hopper is an NHMRC Senior Principal Research Fellow. D.D. Buchanan is a University of Melbourne Research at Melbourne Accelerator Program (R@MAP) Senior Research Fellow. A.C. Antoniou is a Cancer Research UK Senior Research Fellow (C12292/A11174).